(Q42791977)

English

Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis

scientific article published on 23 November 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

0 references

circulatory system

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

based on heuristic

inferred from title

Vasilios G. Athyros

1

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Dimitri P Mikhailidis

10

object named as

Dimitri P Mikhailidis

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Efstathios D Pagourelias

7

object named as

Efstathios D Pagourelias

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

author name string

Konstantinos Tziomalos

2

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Thomas D Gossios

3

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Theodora Griva

4

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Panagiotis Anagnostis

5

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Konstantinos Kargiotis

6

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Eleni Theocharidou

8

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Asterios Karagiannis

9

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

GREACE Study Collaborative Group

11

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

language of work or name

0 references

publication date

23 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

376

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

9756

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

1916-1922

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Impact of statin dosing intensity on transaminase and creatine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961272-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative safety of atorvastatin 80 mg versus 10 mg derived from analysis of 49 completed trials in 14,236 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961272-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation and management of non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961272-X

7 January 2021

based on heuristic

inferred from DOI database lookup

American Gastroenterological Association medical position statement: nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961272-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961272-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Prescription of statins to dyslipidemic patients affected by liver diseases: a subtle balance between risks and benefits

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961272-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961272-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961272-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961272-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Prescribing statins to patients with nonalcoholic fatty liver disease: real cardiovascular benefits outweigh theoretical hepatotoxic risk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961272-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased survival of subjects with elevated liver function tests during a 28-year follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961272-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961272-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961272-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Early benefit from structured care with atorvastatin in patients with coronary heart disease and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961272-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Ev

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961272-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of patients with nonalcoholic fatty liver

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961272-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Pleiotropic effects of statins--clinical evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961272-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of coronary atherosclerotic disease with liver transaminase level

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961272-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Additive prognostic value of gamma-glutamyltransferase in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961272-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Beta-lipoprotein- and LDL-associated serum gamma-glutamyltransferase in patients with coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961272-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961272-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of atorvastatin and diet on non-alcoholic fatty liver disease activity score in hyperlipidemic chickens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961272-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment with atorvastatin ameliorates hepatic very-low-density lipoprotein overproduction in an animal model of insulin resistance, the fructose-fed Syrian golden hamster: evidence that reduced hypertriglyceridemia is accompanied by improved hepat

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961272-X

7 January 2021

based on heuristic

inferred from DOI database lookup

How many components for the metabolic syndrome? Results of exploratory factor analysis in the FIBAR study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961272-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961272-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: new evidence for direct antiinflammatory effects of statins.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961272-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961272-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961272-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(10)61272-X

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42791977&oldid=1970553724"